Clinical Trials Directory

Trials / Conditions / Metastatic Castration-sensitive Prostate Cancer

Metastatic Castration-sensitive Prostate Cancer

9 registered clinical trials studyying Metastatic Castration-sensitive Prostate Cancer — 2 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingAdaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer
NCT06734130
H. Lee Moffitt Cancer Center and Research InstitutePhase 2
RecruitingSaruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician
NCT06120491
AstraZenecaPhase 3
CompletedA Study Called AWARENESS Using Data From Men in Alberta to Observe Treatment Patterns for Metastatic Castratio
NCT05149131
Bayer—
RecruitingA Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
NCT04729114
Astellas Pharma Global Development, Inc.Phase 1
CompletedTAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer
NCT04887506
Tavanta TherapeuticsPhase 3
CompletedStudy of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic
NCT04666129
Sumitomo Pharma America, Inc.Phase 1
UnknownStudy to Evaluate ctDNA of mCSPC Patients Receiving Apalutamide in Japan
NCT04601441
Kindai UniversityPhase 4
Active Not RecruitingA Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Pre
NCT04497844
Janssen Research & Development, LLCPhase 3
Active Not RecruitingCombining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration S
NCT02020070
Memorial Sloan Kettering Cancer CenterPhase 2